Browsed by
Tag: 21st Century Cures

Science policy news: weekly roundup: February 12, 2016 ?>

Science policy news: weekly roundup: February 12, 2016

The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to smartin@asbmb.org for inclusion in next week’s roundup. The American Society for Biochemistry and Molecular Biology hosted a summit in Washington, D.C. to discuss the sustainability of the biomedical research enterprise.

Legislative Update – Appropriations and the Senate innovation agenda ?>

Legislative Update – Appropriations and the Senate innovation agenda

As discussed last week, the appropriations process continues to progress behind closed doors. However, some details are emerging. All appropriations subcommittees have received their 302(b) allocations, and those allocations have been described to me by congressional staff as “fair.” The allocation for the Labor, Health and Human Services appropriations subcommittee, which funds the National Institutes of Health, is said to be “generous.” The original allocation for L-HHS had been below the fiscal year 2015 level, but it seems the Bipartisan…

Read More Read More

Advocacy Spotlight: Melanie Alvarado ?>

Advocacy Spotlight: Melanie Alvarado

ASBMB’s Advocate Spotlight will highlight the efforts of science advocates to share the importance of biomedical research. If you know someone telling the story of science to legislators to advance science policy, emailsmartin@asbmb.org, so that we can consider them. Melanie Alvarado is a graduate student at the University of Alaska Anchorage and studies HIV reactivation within cells that are hidden from a patient’s immune system. 

21st Century Cures Heads to the Senate ?>

21st Century Cures Heads to the Senate

With bipartisan support, the 21st Century Cures Act was passed on the floor of the House of Representatives by a vote of 344-77 after overcoming a variety of political challenges.  This bill provides $1.86 billion per year in mandatory funding for the National Institutes of Health from fiscal 2016 to FY20 through an innovation fund and seeks to streamline the approval process for drugs from the Food and Drug Administration.

House Passes 21st Century Cures ?>

House Passes 21st Century Cures

ASBMB Statement on Passage of HR6 Today, the 21st Century Cures Act was passed on the floor of the House of Representatives by a vote of 344-77.  Cures has drawn bipartisan support with the goal of increasing funding for the National Institutes of Health and streamlining the pathway for new drugs to reach patients.

Floor debate begins on HR 6 – 21st Century Cures ?>

Floor debate begins on HR 6 – 21st Century Cures

With debate starting – here’s a summary of where the legislation stands as it heads to the House floor. If you’ve been following the progress of H.R. 6, the 21st Century Cures Act, you’ve seen momentum for the bill grow, and may have felt (like we did) that its passage is a foregone conclusion. It was only a few weeks ago that we reported on the House Energy and Commerce Committee’s bipartisan and unanimous passage of the bill out of…

Read More Read More